Comparative Pharmacology
Head-to-head clinical analysis: AVAGARD versus CIDA STAT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AVAGARD versus CIDA STAT.
AVAGARD vs CIDA-STAT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Avagard (chlorhexidine gluconate 1% and isopropyl alcohol 61%) is an antiseptic with bactericidal activity. Chlorhexidine disrupts cell membranes and precipitates cell contents; isopropyl alcohol denatures proteins and dissolves lipids.
CIDA-STAT is a hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor that competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to increased hepatic LDL receptor expression and reduced plasma LDL cholesterol levels.
Chlorhexidine gluconate 2% + isopropyl alcohol 70% solution: apply 5 mL to each hand and forearm, rub vigorously for 2-3 minutes, allow to dry; repeat once. For surgical hand antisepsis: apply 5 mL to hands and forearms, scrub for 3 minutes, rinse, repeat.
10 mg orally once daily
None Documented
None Documented
Terminal elimination half-life is 4-6 hours in patients with normal renal function; prolonged to 18-24 hours in severe renal impairment (CrCl <30 mL/min).
Terminal half-life: 12-15 hours; requires dose adjustment in renal impairment (CrCl <30 mL/min)
Primarily renal (unchanged drug and metabolites) with approximately 20-30% excreted fecally; renal clearance accounts for >60% of total clearance.
Renal: 30% unchanged; Biliary/fecal: 60% as metabolites; 10% other
Category C
Category C
Antiseptic
Antiseptic